See more : GEOCODE CO.,Ltd. (7357.T) Income Statement Analysis – Financial Results
Complete financial analysis of Abnova (Taiwan) Corporation (4133.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Abnova (Taiwan) Corporation, a leading company in the Biotechnology industry within the Healthcare sector.
- uniQure N.V. (QURE) Income Statement Analysis – Financial Results
- Recordati Industria Chimica e Farmaceutica S.p.A. (REC.MI) Income Statement Analysis – Financial Results
- RIV Capital Inc. (CNPOF) Income Statement Analysis – Financial Results
- Universal Health Services, Inc. (UHS) Income Statement Analysis – Financial Results
- Heineken N.V. (HEINY) Income Statement Analysis – Financial Results
Abnova (Taiwan) Corporation (4133.TW)
About Abnova (Taiwan) Corporation
Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company's products portfolio includes SARS-CoV/CoV-2, DNA and RNA, proteins/peptides, DNAxPab, beads/dyes, lysates/slides, antibody pairs/kits, antibody and tissue arrays, in situ hybridization products, systems and automations, GMP and analyte specific reagents, and in vitro diagnostics. It also provides MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies. In addition, the company offers integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; antibody production; and assay development services. Abnova (Taiwan) Corporation is headquartered in Taipei, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 382.05M | 411.76M | 451.49M | 456.45M | 414.16M | 426.02M | 475.07M | 439.83M | 451.37M | 438.11M | 463.70M | 463.77M | 472.57M | 475.07M | 402.83M |
| Cost of Revenue | 208.14M | 210.33M | 254.15M | 242.95M | 228.81M | 240.64M | 246.21M | 233.17M | 237.66M | 214.36M | 227.51M | 209.55M | 204.03M | 193.41M | 172.01M |
| Gross Profit | 173.92M | 201.43M | 197.34M | 213.50M | 185.35M | 185.38M | 228.87M | 206.66M | 213.71M | 223.75M | 236.19M | 254.23M | 268.54M | 281.67M | 230.82M |
| Gross Profit Ratio | 45.52% | 48.92% | 43.71% | 46.77% | 44.75% | 43.51% | 48.18% | 46.99% | 47.35% | 51.07% | 50.94% | 54.82% | 56.83% | 59.29% | 57.30% |
| Research & Development | 38.40M | 48.74M | 53.14M | 50.96M | 54.74M | 56.62M | 52.70M | 48.55M | 48.86M | 42.74M | 40.67M | 38.56M | 28.86M | 30.64M | 27.95M |
| General & Administrative | 46.12M | 47.22M | 59.37M | 55.89M | 58.20M | 66.55M | 70.86M | 62.60M | 64.95M | 65.51M | 60.58M | 64.96M | 60.18M | 59.28M | 52.90M |
| Selling & Marketing | 45.26M | 40.35M | 39.81M | 45.12M | 42.54M | 44.75M | 42.15M | 46.99M | 48.83M | 53.02M | 55.68M | 59.28M | 59.24M | 59.76M | 56.70M |
| SG&A | 88.33M | 87.57M | 99.18M | 101.01M | 100.74M | 111.30M | 113.00M | 109.59M | 113.77M | 118.53M | 116.25M | 124.24M | 119.42M | 119.04M | 109.61M |
| Other Expenses | 0.00 | 27.05M | -7.67M | -9.29M | -1.30M | 17.45M | 12.78M | 8.66M | 4.54M | 15.12M | 9.43M | 997.00K | 1.66M | 1.21M | 1.49M |
| Operating Expenses | 126.72M | 136.31M | 152.32M | 151.97M | 155.47M | 163.75M | 169.88M | 158.14M | 162.63M | 161.28M | 156.92M | 162.80M | 148.28M | 149.68M | 137.56M |
| Cost & Expenses | 334.86M | 346.63M | 406.47M | 394.92M | 384.28M | 404.39M | 416.08M | 391.31M | 400.29M | 375.64M | 384.43M | 372.35M | 352.31M | 343.08M | 309.57M |
| Interest Income | 10.53M | 3.64M | 716.00K | 941.00K | 1.67M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.65M | 5.62M | 3.71M | 1.21M |
| Interest Expense | 142.00K | 152.00K | 246.00K | 275.00K | 364.00K | 0.00 | 29.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.00K | 185.00K | 924.00K |
| Depreciation & Amortization | 32.31M | 34.49M | 42.05M | 44.07M | 46.83M | 40.93M | 36.50M | 35.79M | 36.19M | 38.72M | 39.33M | 40.16M | 46.08M | 60.59M | 69.83M |
| EBITDA | 81.21M | 130.30M | 79.79M | 97.26M | 75.41M | 78.53M | 108.26M | 84.31M | 87.26M | 81.36M | 118.59M | 134.49M | 175.63M | 188.38M | 162.49M |
| EBITDA Ratio | 21.26% | 31.64% | 17.67% | 21.31% | 18.21% | 18.66% | 23.03% | 19.17% | 19.33% | 23.10% | 25.58% | 29.06% | 37.00% | 39.56% | 40.44% |
| Operating Income | 47.19M | 95.81M | 37.74M | 53.19M | 28.58M | 21.63M | 58.99M | 48.52M | 51.07M | 62.48M | 79.27M | 91.42M | 120.26M | 131.99M | 93.27M |
| Operating Income Ratio | 12.35% | 23.27% | 8.36% | 11.65% | 6.90% | 5.08% | 12.42% | 11.03% | 11.32% | 14.26% | 17.09% | 19.71% | 25.45% | 27.78% | 23.15% |
| Total Other Income/Expenses | 1.32M | -850.00K | -8.73M | -8.62M | -28.90M | 15.48M | 13.89M | 8.51M | 4.37M | 14.92M | 9.23M | 6.32M | 9.29M | -4.61M | -1.54M |
| Income Before Tax | 48.52M | 94.96M | 36.29M | 49.05M | 980.00K | 37.11M | 72.87M | 57.03M | 55.45M | 77.40M | 88.50M | 94.63M | 129.31M | 127.38M | 91.73M |
| Income Before Tax Ratio | 12.70% | 23.06% | 8.04% | 10.75% | 0.24% | 8.71% | 15.34% | 12.97% | 12.28% | 17.67% | 19.08% | 20.40% | 27.36% | 26.81% | 22.77% |
| Income Tax Expense | 4.84M | 20.11M | 7.93M | 12.52M | -2.28M | -9.01M | 13.91M | 3.49M | 10.54M | 11.75M | 15.60M | 17.79M | 9.45M | -21.66M | -7.83M |
| Net Income | 43.68M | 74.84M | 28.37M | 36.53M | 3.26M | 46.12M | 58.97M | 53.54M | 44.91M | 65.64M | 72.90M | 76.84M | 119.87M | 149.05M | 99.56M |
| Net Income Ratio | 11.43% | 18.18% | 6.28% | 8.00% | 0.79% | 10.83% | 12.41% | 12.17% | 9.95% | 14.98% | 15.72% | 16.57% | 25.36% | 31.37% | 24.71% |
| EPS | 0.72 | 1.24 | 0.47 | 0.60 | 0.05 | 0.76 | 0.97 | 0.91 | 0.74 | 1.05 | 1.17 | 1.27 | 1.93 | 2.40 | 1.75 |
| EPS Diluted | 0.72 | 1.23 | 0.47 | 0.60 | 0.05 | 0.76 | 0.97 | 0.91 | 0.74 | 1.05 | 1.17 | 1.27 | 1.93 | 2.40 | 1.75 |
| Weighted Avg Shares Out | 60.55M | 60.55M | 60.55M | 60.55M | 60.55M | 60.55M | 60.55M | 58.79M | 61.12M | 62.12M | 62.12M | 62.12M | 62.12M | 62.12M | 56.62M |
| Weighted Avg Shares Out (Dil) | 60.63M | 60.66M | 60.60M | 60.59M | 60.57M | 60.63M | 60.65M | 58.89M | 61.19M | 62.21M | 62.21M | 62.24M | 62.21M | 62.16M | 56.63M |
Source: https://incomestatements.info
Category: Stock Reports